DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Farglitazar
Farglitazar
Dualism of Peroxisome Proliferator-Activated Receptor Α/Γ: a Potent Clincher in Insulin Resistance
Synthesis of a Coumarin-Based PPAR Fluorescence Probe for Competitive Binding Assay
The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
Regulation of Enac-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors
Modulation of Cardiometabolic Syndrome Through Peroxisome Proliferator Activator Receptors (Ppars)
REVIEW Thyroid Hormone Receptors Regulate Adipogenesis and Carcinogenesis Via Crosstalk Signaling with Peroxisome Proliferator-A
Peroxisome Proliferator-Activated Receptor ; Pathway Targeting in Carcinogenesis: Implications for Chemoprevention Frank Ondrey
Comparative Molecular Profiling of the PPAR/ Activator
Structural Basis for Telmisartan-Mediated Partial Activation of PPAR Gamma
Refinement of the Docking Component of Virtual Screening for Pparγ Therapeutics Using Pharmacophore Analysis and Molecular Dynamics
REVIEW Thyroid Hormone Receptors Regulate Adipogenesis And
Development of Knowledge Within a Chemical-Toxicological Database to Formulate Novel Computational Approaches for Predicting
Structural Determinants of Ligand Binding Selectivity Between the Peroxisome Proliferator- Activated Receptors
Stembook 2018.Pdf
GI262570, a Peroxisome Proliferator-Activated Receptor Agonist, Changes Electrolytes and Water Reabsorption from the Distal Neph
Product Monograph
Small-Molecule Modulation of Ppars for the Treatment of Prevalent Vascular Retinal Diseases
Approach to a Safer Insulin Sensitizer
Top View
Peroxisome Proliferator Activated Receptors
Customs Tariff - Schedule
PPAR Agonists, Modulation of Ion Transporters, and Fluid Retention
The Role of Lipid Sensing Nuclear Receptors (Ppars and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD
The Role of Peroxisome Proliferator-Activated Receptors in Human Disease
REVIEW Thyroid Hormone Receptors Regulate Adipogenesis And
Doc. Ref. EMEA/386453/2008 P/60/2008 EUROPEAN
Pharmaabkommen A1 E
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia
Ppars Are a Unique Set of Fatty Acid Regulated Transcription Factors Controlling Both Lipid Metabolism and Inflammation Tamas Varga, Zsolt Czimmerer, Laszlo Nagy
Selective Modulators of PPAR-Γ Activity: Molecular Aspects Related to Obesity and Side-Effects
Peroxisome Proliferator-Activated Receptor Alpha: Insight Into the Structure, Function and Energy Homeostasis
Journal of Clinical and Diagnostic Research
Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
Compositions and Methods for Treating Contracture
Supplementary Materials: Building and Testing Pparγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain
The Application of Molecular Modelling in the Safety Assessment of Chemicals: a Case Study
2U11/1271U6 Al
PPAR-Alpha/Gamma AGONISTS
Review Article Selective Modulators of PPAR-Γ Activity: Molecular Aspects Related to Obesity and Side-Effects
Kernel Methods for Virtual Screening
9428749.Pdf (3.634Mb)
Pleiotropic Effects of Glitazones: a Double Edge Sword?
A Pharmacogenetic Approach to the Treatment of Patients with PPARG Mutations
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Cardiovascular Diabetology Biomed Central
Tyrosine Agonists Reverse the Molecular Defects Associated with Dominant-Negative Mutations in Human Peroxisome Proliferator-Activated Receptor ␥
Peroxisome Proliferator-Activated Receptors and Their Ligands: Nutritional and Clinical Implications – Areview Bogna Grygiel-Górniak
Q:\Users\Brendac\Pharmaceutical Zeroforzero Initiative FINAL Edited
Concentration-Response Modeling in High-Throughput Transcriptomics
The Role of Nuclear Receptors in the Kidney in Obesity and Metabolic Syndrome
1 a Pharmacogenetic Approach to the Treatment of Patients With
The Development of INT131 As a Selective Pparγ Modulator: Approach to a Safer Insulin Sensitizer